Prostatis Group’s State Street SPDR Portfolio Emerging Markets ETF SPEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
+4,802
New +$246K 0.06% 158
2023
Q3
Sell
-33,120
Closed -$33.1K 216
2023
Q2
$33.1K Buy
+33,120
New +$1.13M 0.02% 207
2022
Q1
Sell
-5,985
Closed -$248K 98
2021
Q4
$248K Sell
5,985
-1,628
-21% -$69.6K 0.15% 88
2021
Q3
$324K Sell
7,613
-353
-4% -$15.3K 0.19% 75
2021
Q2
$362K Sell
7,966
-3,032
-28% -$136K 0.25% 72
2021
Q1
$481K Sell
10,998
-3,303
-23% -$148K 0.38% 61
2020
Q4
$603K Sell
14,301
-7,436
-34% -$295K 0.5% 47
2020
Q3
$795K Buy
21,737
+11,981
+123% +$437K 0.75% 35
2020
Q2
$326K Buy
+9,756
New +$305K 0.66% 43

Other funds holding SPEM

Prostatis Group's SPEM Position: Q2 2026 in Review

Prostatis Group opened a new position in State Street SPDR Portfolio Emerging Markets ETF (SPEM) in Q2 2026: 4,802 shares worth $249K. The stake represents 0.06% of the portfolio and ranks #158 among its holdings. This is a return to the name: Prostatis Group previously reported a position in SPEM as recently as Q2 2023.

Prostatis Group first reported a position in SPEM in Q2 2020 and has held it in 9 quarters since. The position peaked at $795K in Q3 2020. 1,033 funds tracked by Wall St. Rank hold SPEM as of Q2 2026.

  • Prostatis Group held 4,802 shares of State Street SPDR Portfolio Emerging Markets ETF worth $249K as of Q2 2026.
  • State Street SPDR Portfolio Emerging Markets ETF was a new Prostatis Group position in Q2 2026.
  • State Street SPDR Portfolio Emerging Markets ETF made up 0.06% of Prostatis Group's portfolio in Q2 2026, its #158 holding.
  • Prostatis Group first reported a position in State Street SPDR Portfolio Emerging Markets ETF in Q2 2020 and has held it in 9 quarters since.
  • Prostatis Group's State Street SPDR Portfolio Emerging Markets ETF position peaked at $795K in Q3 2020.
  • 1,033 funds tracked by Wall St. Rank held State Street SPDR Portfolio Emerging Markets ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.